Mycotoxin binders are feed additives that latch onto toxic fungal metabolites in the gut of an animal, preventing those toxins from being absorbed into the bloodstream. They work by trapping mycotoxins on their surface through physical and chemical attraction, so the toxin-binder complex passes harmlessly through the digestive tract and out in the feces. The concept is straightforward, but the reality is messier: no single binder grabs every mycotoxin equally well, some binders also grab nutrients you want the animal to keep, and the field is evolving fast as climate shifts push new contamination patterns into regions that were previously low-risk.
How Binders Trap Mycotoxins
Most mycotoxin binders fall into two broad families: mineral-based and organic. Mineral binders include clays like bentonite, montmorillonite, and zeolites (clinoptilolite is the most common zeolite used). These materials have layered or porous structures with enormous surface area relative to their mass. Mycotoxin molecules settle into these layers or pores and are held in place by a combination of surface adsorption, ion exchange, and hydrogen bonding. A modified bentonite composite, for example, uses the layered clay structure for ion exchange while added humic acid contributes carboxylic and phenolic groups that form selective hydrogen bonds with specific toxins.1PubMed Central. Optimization of modified bentonite mycotoxin binders for enhanced adsorption efficiency under simulated gastric and intestinal conditions
On the organic side, the most widely used materials are derived from yeast cell walls. The active ingredient is beta-D-glucan, a polysaccharide whose branching, net-like molecular structure can trap mycotoxin molecules in its folds. The interaction relies on weak hydrogen bonds and van der Waals forces, making it more of an adsorption process than a tight chemical lock.2Journal of Animal and Feed Sciences. How yeast cell wall components can alleviate mycotoxicosis in animal production and improve the safety of edible animal products Because these bonds are relatively weak, the ratio of different glucan chain types and how tightly the glucan network is organized both matter for how much toxin the material can hold. Activated carbon, a third category, works through a different principle: its vast internal pore network physically traps a wide range of molecules, which makes it less selective but often more broadly effective in laboratory tests.
The Selectivity Problem
This is where the gap between marketing claims and lab results gets wide. Most clay-based binders are very good at grabbing aflatoxin B1, the most acutely dangerous mycotoxin in animal feed. But feed contamination rarely involves just one toxin. Deoxynivalenol (DON, sometimes called vomitoxin), zearalenone, fumonisins, and ochratoxin A frequently co-occur with aflatoxins, and many binders that excel at trapping aflatoxin barely touch the others.
In vitro testing bears this out consistently. One study screening multiple commercial binders found that activated charcoal sequestered over 99% of DON, while every other product tested failed to sequester it effectively. For zearalenone, only a specific bentonite formulation, one aluminosilicate, and activated charcoal achieved high capture rates; the rest did not.3PubMed Central. An In Vitro Study on the Efficacy of Mycotoxin Sequestering Agents for Aflatoxin B1, Deoxynivalenol, and Zearalenone A separate study tested sorbents against eight mycotoxins simultaneously under simulated gastric conditions and found that activated charcoal was the only material that bound all eight with high efficiency. The runner-up, sepiolite, managed most but fell short on DON. Every other sorbent tested could handle three or fewer mycotoxins.4PubMed Central. The efficiency of mycotoxin binding by sorbents in the in vitro model using a naturally contaminated animal feed
DON in particular has been a persistent headache. Across 14 adsorbent materials tested at pH levels spanning the full gastrointestinal range, only activated carbon showed meaningful binding capacity for DON and the related toxin nivalenol.5PubMed. Evaluation of the intestinal absorption of deoxynivalenol and nivalenol by an in vitro gastrointestinal model, and the binding efficacy of activated carbon and other adsorbent materials And in live-animal trials, even hydrated sodium calcium aluminosilicate (HSCAS), one of the best-studied clay binders, failed to protect chicks and young turkeys fed diets contaminated with a realistic cocktail of DON, moniliformin, fumonisin, aflatoxin, zearalenone, and ochratoxin. Similar failures were reported in pigs fed DON-contaminated diets with HSCAS added.6ResearchGate. Evaluation of mycotoxin binders The practical takeaway: a binder labeled as “mycotoxin protection” might protect against one toxin but leave an animal exposed to others.
What Binders Actually Do in Live Animals
Despite the selectivity limitations, well-matched binders produce real improvements in animal performance when the dominant contaminant is one they can handle. In broiler chickens exposed to aflatoxin B1, adding a clay-and-yeast-based binder at one gram per kilogram of feed improved body weight gain across the entire grow-out period and significantly reduced the swelling of liver, kidney, and pancreas that aflatoxin exposure typically causes.7PubMed Central. The Effect of Clay- and Yeast-Based Mycotoxin Binder on Performance, Lymphoid Organs, Blood Parameters, Immune Response and Haematology Parameters of Broilers Exposed to Aflatoxin B(1) In breeding sows exposed to zearalenone, a silicoglycidol-based binder increased zearalenone concentration in feces (meaning less was absorbed) and reduced the incidence of vulvitis, a zearalenone-driven reproductive problem, by about 23%.8Veterinaria Digital. Efficiency of Silicoglycidol as mycotoxin binder (zearalenone) in breeding sows
Aquaculture is a growing market for binders. In Nile tilapia fed mycotoxin-contaminated diets, adding a binder at the lowest tested dose (one gram per kilogram of feed) yielded the highest net profit because the improvement in growth and feed efficiency more than offset the cost of the additive. Interestingly, higher binder doses increased feed cost without proportionally increasing returns, so there is an economic sweet spot.9Aquaculture Reports. Studies on the use of mycotoxin binders as an effective strategy to mitigate mycotoxin contamination in aquafeed: A case study in Nile tilapia (Oreochromis niloticus)
Keeping Mycotoxins Out of Milk
When dairy cows eat aflatoxin B1 in contaminated feed, their livers convert a fraction of it into aflatoxin M1, which ends up in the milk. Regulatory limits on aflatoxin M1 in milk are strict in most countries, so even moderate feed contamination can make milk unsaleable. Binders offer a way to intercept the toxin before it reaches the liver.
In a controlled trial with dairy cows fed aflatoxin-contaminated diets, five of six sequestering agents significantly reduced aflatoxin M1 in milk. Reductions ranged from about 31% for one product up to 65% for the best performer. One surprise: activated carbon, usually a strong performer in lab tests, had no effect on M1 transfer to milk at the inclusion rate tested.10PubMed. Aflatoxin binders II: reduction of aflatoxin M1 in milk by sequestering agents of cows consuming aflatoxin in feed In a field study across multiple dairy farms, clinoptilolite (a natural zeolite) reduced milk aflatoxin M1 concentrations by an average of about 56% within seven days of supplementation.11PubMed Central. In-field evaluation of clinoptilolite feeding efficacy on the reduction of milk aflatoxin M1 concentration in dairy cattle That is a meaningful drop, though it does not eliminate the toxin entirely. In practice, binders work best as part of a larger strategy that includes sourcing cleaner feed and testing milk regularly.
The Nutrient-Grabbing Trade-Off
A binder that sits in the gut and adsorbs molecules is not perfectly selective. If it grabs mycotoxins, it may also grab amino acids, vitamins, or minerals that the animal needs. This is the most important safety concern with binder use, and it applies across binder types.
In vitro experiments have shown that common binders can adsorb a substantial share of amino acids and water-soluble vitamins. The average adsorption rate for amino acids across binder types was over 44%, and for water-soluble vitamins it reached 34% when vitamins were tested individually and 45% when tested together, suggesting the vitamins may even compete with each other for binding sites.12PubMed. In vitro assessment of the capacity of certain mycotoxin binders to adsorb some amino acids and water-soluble vitamins Clinoptilolite was particularly aggressive with certain amino acids, while activated carbon, despite being a weaker amino acid grabber, still pulled in nutrients.
For human applications, a review of aflatoxin-sequestering clays laid out the criteria any binder should meet before wide deployment: favorable mycotoxin binding thermodynamics, tolerable levels of heavy metals and dioxins in the clay itself, proven safety across species, long-term safety data, and negligible interactions with vitamins, iron, zinc, and other micronutrients.13PubMed. Reducing human exposure to aflatoxin through the use of clay: a review That last criterion, nutrient sparing, is where many commercial products still fall short. The lesson for farmers and feed formulators: if you add a binder, you may need to bump up vitamin and mineral supplementation to compensate for what the binder steals.
Blended and Engineered Binders
Because no single material covers all mycotoxins, the industry has moved toward composite products that combine mineral and organic components. The logic is that the clay fraction handles aflatoxins and certain other toxins while the yeast or glucan fraction covers the ones clay misses. Optimizing these blends is where a lot of current research sits.
A formulation combining bentonite, humic acid, and beta-glucan-mannan in a 70:10:20 ratio achieved some of the broadest coverage reported under simulated gut conditions: over 98% removal of aflatoxin B1, around 94% for aflatoxin B2 and G2, 91% for aflatoxin G1, about 82% for ochratoxin, 73% for zearalenone, and 99% for deoxynivalenol.14PubMed Central. Optimization of modified bentonite mycotoxin binders for enhanced adsorption efficiency under simulated gastric and intestinal conditions The DON figure is especially striking given how poorly most binders handle that toxin.
Surface modification of clays is another active research direction. Acid-activated bentonite functionalized with organic molecules produced a bio-organoclay that, at low inclusion rates, sequestered over 95% of aflatoxin B1, fumonisin B1, ochratoxin A, and zearalenone across a wide pH range. In a rat study, the material reduced urinary markers of aflatoxin M1 by 94%, ochratoxin A by 54%, and fumonisin B1 by 40%.15The FASEB Journal. In Vitro and In Vivo Efficacy Assessment of a New Bentonite Based Material Acting as a Multi‐mycotoxin Binder Nano-scale versions of modified montmorillonite have also shown promise in rat studies, preventing or diminishing liver and kidney damage from combined aflatoxin B1 and ochratoxin A exposure without producing toxic effects of their own.16Soft Nanoscience Letters. Efficacy of Organo-Modified Nano Montmorillonite to Protect against the Cumulative Health Risk of Aflatoxin B1 and Ochratoxin A in Rats
Agricultural Byproducts as Low-Cost Alternatives
Not every binder needs to come out of a factory. Grape pomace, the skin-and-seed residue left after winemaking, has shown real mycotoxin-binding activity in live animals. When fed to piglets alongside a cocktail of mycotoxins, white grape pomace from the Malvasia variety reduced urinary biomarkers of aflatoxin B1 by 67% and zearalenone by 69%, with non-significant but notable reductions for fumonisin B1 (57%), DON (40%), and ochratoxin A (27%).17Journal of Agricultural and Food Chemistry. Grape Pomace, an Agricultural Byproduct Reducing Mycotoxin Absorption: In Vivo Assessment in Pig Using Urinary Biomarkers The appeal is obvious: grape pomace is cheap, abundant in winemaking regions, and would otherwise be waste. Whether it can be standardized enough for commercial feed manufacturing remains an open question, but the proof of concept is solid.
Beyond Binding: Enzymatic Biotransformation
Binders are not the only game in town. Enzymatic biotransformation takes a fundamentally different approach: instead of trapping the toxin intact and flushing it out, specialized enzymes chemically break the toxin molecule into non-toxic fragments. Enzymes isolated from bacteria, fungi, and plants have been validated in both lab and animal studies, and some commercial preparations are already on the market.18PubMed Central. Mycotoxin Biotransformation by Native and Commercial Enzymes: Present and Future Perspectives The advantage is that enzymatic degradation does not risk binding nutrients. The disadvantage is that each enzyme tends to target a specific toxin, so you still need multiple tools for multi-toxin contamination. Most current products combine a binder (for aflatoxin) with an enzyme (for one or two Fusarium toxins), hedging both strategies.
Human Applications and the Regulatory Gap
Most mycotoxin binder research and commercial use sits squarely in the animal feed sector, but there is growing interest in direct human applications. In parts of sub-Saharan Africa and Southeast Asia, where smallholder farmers eat grain that would fail import standards in wealthier countries, dietary binders could reduce chronic aflatoxin exposure. Small clinical trials have tested calcium montmorillonite clay (NovaSil) as a human supplement and reported reduced aflatoxin biomarkers in blood and urine without obvious adverse effects over study periods of a few months. Activated carbons and certain bacterial strains have also been proposed as dietary agents for mycotoxin reduction, though the research community has acknowledged that verifying long-term safety, confirming how these agents actually work in the human gut, and assessing economic feasibility all require far more work.19ScienceDirect. Dietary Strategies to Counteract the Effects of Mycotoxins: A Review No regulatory agency in Europe or North America currently authorizes a mycotoxin binder as a human food additive; the products remain approved only for use in animal feed or, in the case of NovaSil, under research protocols.
Why Climate Change Is Making Binders More Relevant
Mycotoxin contamination is not a fixed problem. The fungi that produce these toxins respond to temperature, humidity, and drought stress, which means that as climate patterns shift, contamination patterns shift with them. In Europe, rising temperatures have been creating steadily more favorable conditions for Aspergillus flavus, the mold behind aflatoxin. Regions in northern and central Europe that historically worried mostly about Fusarium toxins like DON are now seeing increased contamination from Fusarium graminearum, a species capable of producing several toxic metabolites simultaneously.20PubMed Central. Climate Change-A Global Threat Resulting in Increasing Mycotoxin Occurrence For feed manufacturers and livestock producers, the practical implication is that a binder strategy designed around last decade’s contamination profile may not match what is showing up in grain supplies today. Multi-toxin binders and regular mycotoxin screening are becoming less of a luxury and more of a baseline.
Mycotoxins After They Leave the Animal
One often-overlooked dimension of the binder conversation is what happens to toxin-laden feces and manure after they leave the barn. When a binder successfully captures a mycotoxin in the gut and escorts it out in the feces, that toxin does not vanish. Manure applied to agricultural fields introduces mycotoxins into soil, where their fate depends heavily on soil texture. Clays in the soil itself adsorb mycotoxins and hold them in place, while sandy soils allow them to leach into groundwater. Mycotoxin levels detected in agricultural soils have reached concentrations in the microgram-per-kilogram range for zearalenone, deoxynivalenol, ochratoxin A, and others, and different compartments in the agroecosystem, from water to sewage sludge, each harbor at least one mycotoxin.21PubMed Central. Mycotoxins in soil and environment The environmental significance of these levels is still being assessed, but it raises an interesting irony: the better your binder works, the more toxin ends up concentrated in manure. That is not an argument against binders, since the alternative is having the toxin pass through the animal’s organs instead. But it does mean that manure management is part of the mycotoxin control picture, not separate from it.
The Ancient Practice Behind the Modern Product
Feeding clay to neutralize dietary toxins is far from a modern invention. The practice of geophagy, deliberately eating earth or clay, has been documented in humans across cultures and continents for millennia, and it shows up in non-human primates as well. Research has connected geophagy to detoxification rather than mere mineral supplementation: clays consumed by indigenous communities effectively adsorb plant toxins like glycoalkaloids, which would otherwise make wild potatoes and other plants dangerously bitter and toxic.22PubMed. Detoxification function of geophagy and domestication of the potato Even more striking, a clay recovered from an archaeological site occupied by Homo erectus and early Homo sapiens was mineralogically indistinguishable from clays used for geophagy in Africa today and showed equivalent detoxification capacity.23The American Journal of Clinical Nutrition. Detoxification and mineral supplementation as functions of geophagy In a sense, the modern mycotoxin binder industry is industrializing something our ancestors figured out by trial and error hundreds of thousands of years ago: if food makes you sick, eat it with clay.